ICON Public logged a 10.2% change during today's afternoon session, and is now trading at a price of $313.62 per share. The S&P 500 index moved 2.0%. ICLR's trading volume is 1,092,552 compared to the stock's average volume of 536,686.
ICON Public trades 0.22% away from its average analyst target price of $312.93 per share. The 14 analysts following the stock have set target prices ranging from $265.0 to $357.0, and on average have given ICON Public a rating of buy.
If you are considering an investment in ICLR, you'll want to know the following:
-
ICON Public's current price is -77.9% below its Graham number of $69.18, which implies the stock has a margin of safety
-
ICON Public has moved 27.6% over the last year, and the S&P 500 logged a change of 24.2%
-
Based on its trailing earnings per share of 6.21, ICON Public has a trailing 12 month Price to Earnings (P/E) ratio of 50.5 while the S&P 500 average is 15.97
-
ICLR has a forward P/E ratio of 18.4 based on its forward 12 month price to earnings (EPS) of $17.08 per share
-
The company has a price to earnings growth (PEG) ratio of 1.43 — a number near or below 1 signifying that ICON Public is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 2.8 compared to its sector average of 4.08
-
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.